204 related articles for article (PubMed ID: 18290860)
1. Paraoxonase 1 phenotype distribution and activity differs in subjects with newly diagnosed Type 2 diabetes (the CODAM Study).
van den Berg SW; Jansen EH; Kruijshoop M; Beekhof PK; Blaak E; van der Kallen CJ; van Greevenbroek MM; Feskens EJ
Diabet Med; 2008 Feb; 25(2):186-93. PubMed ID: 18290860
[TBL] [Abstract][Full Text] [Related]
2. PON1 status is influenced by oxidative stress and inflammation in coronary heart disease patients.
Kotur-Stevuljevic J; Spasic S; Jelic-Ivanovic Z; Spasojevic-Kalimanovska V; Stefanovic A; Vujovic A; Memon L; Kalimanovska-Ostric D
Clin Biochem; 2008 Sep; 41(13):1067-73. PubMed ID: 18634772
[TBL] [Abstract][Full Text] [Related]
3. Low paraoxonase activity in type II diabetes mellitus complicated by retinopathy.
Mackness B; Durrington PN; Abuashia B; Boulton AJ; Mackness MI
Clin Sci (Lond); 2000 Mar; 98(3):355-63. PubMed ID: 10677395
[TBL] [Abstract][Full Text] [Related]
4. Paraoxonase/arylesterase in serum of patients with type II diabetes mellitus.
Juretić D; Motejlkova A; Kunović B; Rekić B; Flegar-Mestrić Z; Vujić L; Mesić R; Lukac-Bajalo J; Simeon-Rudolf V
Acta Pharm; 2006 Mar; 56(1):59-68. PubMed ID: 16613735
[TBL] [Abstract][Full Text] [Related]
5. Serum oxidized low density lipoprotein, paraoxonase 1 and lipid peroxidation levels during oral glucose tolerance test.
Serin O; Konukoglu D; Firtina S; Mavis O
Horm Metab Res; 2007 Mar; 39(3):207-11. PubMed ID: 17373636
[TBL] [Abstract][Full Text] [Related]
6. Serum paraoxonase phenotype distribution in exudative age-related macular degeneration and its relationship to homocysteine and oxidized low-density lipoprotein.
Javadzadeh A; Ghorbanihaghjo A; Bahreini E; Rashtchizadeh N; Argani H; Alizadeh S
Retina; 2012 Apr; 32(4):658-66. PubMed ID: 22030834
[TBL] [Abstract][Full Text] [Related]
7. The effect of meals rich in thermally stressed olive and safflower oils on postprandial serum paraoxonase activity in patients with diabetes.
Wallace AJ; Sutherland WH; Mann JI; Williams SM
Eur J Clin Nutr; 2001 Nov; 55(11):951-8. PubMed ID: 11641743
[TBL] [Abstract][Full Text] [Related]
8. Association of oxidative stress and PON1 with LDL and HDL particle size in middle-aged subjects.
Vekic J; Kotur-Stevuljevic J; Jelic-Ivanovic Z; Spasic S; Spasojevic-Kalimanovska V; Topic A; Zeljkovic A; Stefanovic A; Zunic G
Eur J Clin Invest; 2007 Sep; 37(9):715-23. PubMed ID: 17696961
[TBL] [Abstract][Full Text] [Related]
9. Activity of paraoxonase 1 (PON1) and its relationship to markers of lipoprotein oxidation in healthy Slovaks.
Sumegová K; Blazícek P; Waczulíková I; Zitnanová I; Duracková Z
Acta Biochim Pol; 2006; 53(4):783-7. PubMed ID: 17106515
[TBL] [Abstract][Full Text] [Related]
10. Serum arylesterase/diazoxonase activity and genetic polymorphisms in patients with type 2 diabetes.
Inoue M; Suehiro T; Nakamura T; Ikeda Y; Kumon Y; Hashimoto K
Metabolism; 2000 Nov; 49(11):1400-5. PubMed ID: 11092501
[TBL] [Abstract][Full Text] [Related]
11. Oxidative stress and high-density lipoprotein function in Type I diabetes and end-stage renal disease.
Kalogerakis G; Baker AM; Christov S; Rowley KG; Dwyer K; Winterbourn C; Best JD; Jenkins AJ
Clin Sci (Lond); 2005 Jun; 108(6):497-506. PubMed ID: 15634192
[TBL] [Abstract][Full Text] [Related]
12. Paraoxonase gene polymorphism and serum activity in progressive IgA nephropathy.
Kovács TJ; Harris S; Vas TK; Seres I; Short CD; Wittmann IK; Paragh G; Mackness MI; Mackness B; Durrington PN; Nagy JM; Brenchley PE
J Nephrol; 2006; 19(6):732-8. PubMed ID: 17173245
[TBL] [Abstract][Full Text] [Related]
13. Oxidative status and serum PON1 activity in beta-thalassemia minor.
Selek S; Aslan M; Horoz M; Gur M; Erel O
Clin Biochem; 2007 Mar; 40(5-6):287-91. PubMed ID: 17296173
[TBL] [Abstract][Full Text] [Related]
14. PON1 55 and 192 gene polymorphisms in type 2 diabetes mellitus patients in a Turkish population.
Ergun MA; Yurtcu E; Demirci H; Ilhan MN; Barkar V; Yetkin I; Menevse A
Biochem Genet; 2011 Feb; 49(1-2):1-8. PubMed ID: 20820904
[TBL] [Abstract][Full Text] [Related]
15. Relationship between human paraoxonase-1 activity and PON1 polymorphisms in Mexican workers exposed to organophosphate pesticides.
López-Flores I; Lacasaña M; Blanco-Muñoz J; Aguilar-Garduño C; Sanchez-Villegas P; Pérez-Méndez OA; Gamboa-Avila R
Toxicol Lett; 2009 Jul; 188(2):84-90. PubMed ID: 19446239
[TBL] [Abstract][Full Text] [Related]
16. Paraoxonase activity in healthy, diabetic, and hemodialysis patients.
Gbandjaba NY; Ghalim N; Hassar M; Berrougui H; Labrazi H; Taki H; Saile R; Khalil A
Clin Biochem; 2012 Apr; 45(6):470-4. PubMed ID: 22285382
[TBL] [Abstract][Full Text] [Related]
17. The relationship of PON1 QR 192 and LM 55 polymorphisms with serum paraoxonase activities of Turkish diabetic patients.
Altuner D; Ates I; Suzen SH; Koc GV; Aral Y; Karakaya A
Toxicol Ind Health; 2011 Nov; 27(10):873-8. PubMed ID: 21505009
[TBL] [Abstract][Full Text] [Related]
18. Distribution of paraoxonase-1 gene polymorphisms and enzyme activity in a Peruvian population.
Cataño HC; Cueva JL; Cardenas AM; Izaguirre V; Zavaleta AI; Carranza E; Hernández AF
Environ Mol Mutagen; 2006 Dec; 47(9):699-706. PubMed ID: 17078098
[TBL] [Abstract][Full Text] [Related]
19. Paraoxonase 55 and 192 polymorphism and its relationship to serum paraoxonase activity and serum lipids in Turkish patients with non-insulin dependent diabetes mellitus.
Agachan B; Yilmaz H; Karaali Z; Isbir T
Cell Biochem Funct; 2004; 22(3):163-8. PubMed ID: 15124181
[TBL] [Abstract][Full Text] [Related]
20. The relationship of oral disturbances of diabetes mellitus patients with paraoxonase gene polymorphisms.
Unür M; Demirez E; Ağaçhan B; Görmüş U; Ergen A; Dalan B; Isbir T
Cell Biochem Funct; 2008 Dec; 26(8):870-3. PubMed ID: 19003935
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]